Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy

Jiaoli Wang; Haoran Hu; Haixia Du; Man Luo; Yilan Cao; Jiaping Xu; Tianhang Chen; Yilei Guo; Qixiang Li; Wen Chen; Yifei Zhang; Jin Han; Haitong Wan

doi:10.3389/fphar.2022.986640

Corrigendum: Clinical efficacy protocol of yinhuapinggan granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of community-acquired drug-resistant bacterial pneumonia as a complementary therapy

Front Pharmacol. 2022 Aug 16:13:986640. doi: 10.3389/fphar.2022.986640. eCollection 2022.

Authors

Jiaoli Wang^{1

2}, Haoran Hu³, Haixia Du⁴, Man Luo², Yilan Cao³, Jiaping Xu³, Tianhang Chen⁴, Yilei Guo³, Qixiang Li³, Wen Chen³, Yifei Zhang⁵, Jin Han³, Haitong Wan^{1

4}

Affiliations

¹ Zhejiang Chinese Medical University, Hangzhou, China.
² Department of Respiratory Medicine, Hangzhou First People's Hospital, Hangzhou, China.
³ College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
⁴ College of Life Science, Zhejiang Chinese Medical University, Hangzhou, China.
⁵ Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.852604.].

Keywords: Yinhuapinggan (YHPG); clinical efficacy; clinical trial; community-acquired drug-resistant bacterial pneumonia (CDBP); multidrug resistance; traditional Chinese medicine (TCM).

Publication types

Published Erratum